HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients.

Tan, R Y C; Camat, M D; Ng, M; Lim, T H; Lim, A S T; Lim, K H; Tan, I B H

Tan, R Y C; Camat, M D; Ng, M; Lim, T H; Lim, A S T; Lim, K H; Tan, I B H.

Afiliação

Tan RYC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Camat MD; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Ng M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Lim TH; Department of Pathology, Singapore General Hospital, Singapore, Singapore.
Lim AST; Department of Pathology, Singapore General Hospital, Singapore, Singapore.
Lim KH; Department of Pathology, Singapore General Hospital, Singapore, Singapore.
Tan IBH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: iain.tan.b.h@singhealth.com.sg.

Ann Oncol ; 29(7): 1598-1599, 2018 07 01.

Article em En | MEDLINE | ID: mdl-29868843

Assuntos

Biomarcadores Tumorais/metabolismo; Neoplasias Encefálicas/secundário; Neoplasias Colorretais/patologia; Receptor ErbB-2/metabolismo; Neoplasias Encefálicas/metabolismo; Neoplasias Colorretais/metabolismo; Humanos; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Colorretais / Biomarcadores Tumorais / Receptor ErbB-2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google